Founded in December 2016, Shanghai Blueray Biopharma Co.,Ltd. is located in Zhangjiang High-tech Industrial Development Zone, Pudong, Shanghai. The company is invested by Langrun (Shenzhen) equity investment fund company (limited partnership), with registered capital of 30 million yuan.

The company brings together a group of experienced high-end talents in molecular biology, oncology, structural biology, medicinal chemistry and other disciplines. It has established state-of-art biological, protein structural and synthetic laboratories, to support modern drug discovery projects.

Shanghai Blueray Biopharma focuses on first-in-class and/or best-in-class small molecule drug discovery, targeting novel proteins. For the benefits of cancer patients, we are open to any external collaborations on clinical studies to actively promotes the development of our own innovative pre-clinic drug candidates.